USANA Health Sciences (USNA) Stock Price Down 5%

Shares of USANA Health Sciences, Inc. (NYSE:USNA) fell 5% during trading on Friday . The stock traded as low as $75.40 and last traded at $75.53. 500,624 shares changed hands during mid-day trading, an increase of 144% from the average session volume of 204,974 shares. The stock had previously closed at $79.54.

Several equities research analysts recently weighed in on USNA shares. Pivotal Research reissued a “buy” rating and set a $105.00 price target on shares of USANA Health Sciences in a research report on Wednesday, May 1st. Tigress Financial started coverage on shares of USANA Health Sciences in a research report on Tuesday, April 16th. They set a “buy” rating for the company.

The stock has a market cap of $1.86 billion, a price-to-earnings ratio of 14.64 and a beta of 0.30.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, April 30th. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.99 by $0.02. USANA Health Sciences had a net margin of 10.38% and a return on equity of 29.51%. The business had revenue of $272.90 million during the quarter, compared to the consensus estimate of $272.20 million. During the same quarter in the previous year, the firm posted $1.19 EPS. The firm’s revenue was down 6.5% on a year-over-year basis. As a group, equities research analysts predict that USANA Health Sciences, Inc. will post 5.18 EPS for the current year.

A number of large investors have recently bought and sold shares of USNA. Royce & Associates LP grew its position in USANA Health Sciences by 66.4% in the 1st quarter. Royce & Associates LP now owns 381 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the period. NumerixS Investment Technologies Inc bought a new stake in USANA Health Sciences in the 4th quarter worth approximately $34,000. Flagship Harbor Advisors LLC grew its position in USANA Health Sciences by 60.8% in the 4th quarter. Flagship Harbor Advisors LLC now owns 677 shares of the company’s stock worth $79,000 after purchasing an additional 256 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank grew its position in USANA Health Sciences by 23.8% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 858 shares of the company’s stock worth $101,000 after purchasing an additional 165 shares during the period. Finally, Great West Life Assurance Co. Can grew its position in USANA Health Sciences by 43.8% in the 4th quarter. Great West Life Assurance Co. Can now owns 1,516 shares of the company’s stock worth $172,000 after purchasing an additional 462 shares during the period. 54.16% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Modern Readers and is the property of of Modern Readers. If you are reading this piece on another publication, it was stolen and republished in violation of U.S. & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.modernreaders.com/news/2019/05/17/usana-health-sciences-usna-stock-price-down-5.html.

About USANA Health Sciences (NYSE:USNA)

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.

Further Reading: Calculate Your Return on Investment (ROI)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.